APA (7th ed.) Citation

JF, D., M, K., R, B., M, A., EJ, K., JJ, P., . . . VS, K. (2022). Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro: Rationale for a host-acting antiviral treatment strategy for COVID-19. Antiviral research, 206, 105403. https://doi.org/10.1016/j.antiviral.2022.105403

Chicago Style (17th ed.) Citation

JF, Demarest, et al. "Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in Vitro: Rationale for a Host-acting Antiviral Treatment Strategy for COVID-19." Antiviral Research 206 (2022): 105403. https://doi.org/10.1016/j.antiviral.2022.105403.

MLA (9th ed.) Citation

JF, Demarest, et al. "Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 in Vitro: Rationale for a Host-acting Antiviral Treatment Strategy for COVID-19." Antiviral Research, vol. 206, 2022, p. 105403, https://doi.org/10.1016/j.antiviral.2022.105403.